BackEvoke Pharma Overview

Evoke Pharma Current Cash

Track Evoke Pharma's current cash ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$11.58M
↑ 2.09% YoYΔ $236978.00 vs prior year quarter

Peer trimmed avg / median

Loading

Evoke Pharma Current Cash History

Loading

Evoke Pharma vs. peers: Current Cash Comparison

Loading

Evoke Pharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Evoke Pharma (EVOK) FAQ

Evoke Pharma (EVOK) currently reports a current cash of $12M as of September 2025. That compares with $11M in the prior-year period — up 2.1% year over year. Use the charts on this page to explore Evoke Pharma's current cash history and peer comparisons.

Evoke Pharma's current cash increased from $11M to $12M — a 2.1% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evoke Pharma reported $12M in current cash as of September 2025. That compares with $11M in the prior-year period — up 2.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evoke Pharma, and consider following EVOK for alerts when major investors trade the stock.

Evoke Pharma is classified in the Healthcare sector. On current cash, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVOK with unrelated industries.